NCT/Study#
NCT07094204 /
5834-CL-1001
A Phase 1 Study of ASP5834 in Participants with Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies with KRAS Mutations or KRAS Amplifications
DISEASE GROUP:
Colon Cancer Clinical Trials
current phase:
Phase I
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
